Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hanley

Showing results (661-670 of 740) with videos related to

Pageof 74
Sort By:
Diabetologia|October 2, 2025
Prevalence of youth type 2 diabetes in global Indigenous populations: a systematic reviewEmily R Papadimos, Courtney Claussen, Dianna J Magliano, et al.
Blood Advances|November 20, 2020
Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipientsAdam S Nelson, Daria Heyenbruch, Jeremy D Rubinstein, et al.
Blood Advances|September 8, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphomaHema Dave, Madeline Terpilowski, Mimi Mai, et al.
Journal of Clinical Pharmacology|August 12, 2017
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic AnalysisNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
Clinical and Experimental Immunology|June 15, 2013
Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapyC R Y Cruz, S Lam, P J Hanley, et al.
Diabetes Care|September 26, 2022
The Portfolio Diet and Incident Type 2 Diabetes: Findings From the Women's Health Initiative Prospective Cohort StudyAndrea J Glenn, Jie Li, Kenneth Lo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 21, 2024
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplantRuby Khoury, Michael S Grimley, Adam S Nelson, et al.
The American Journal of Clinical Nutrition|February 15, 2023
Sugar-sweetened beverage consumption and weight gain in children and adults: a systematic review and meta-analysis of prospective cohort studies and randomized controlled trialsMichelle Nguyen, Sarah E Jarvis, Maria G Tinajero, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Molecular Therapy. Methods & Clinical Development|May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy productsJessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Pageof 74

Showing results (661-670 of 740) with videos related to

Sort By:
Pageof 74
Diabetologia|October 2, 2025
Prevalence of youth type 2 diabetes in global Indigenous populations: a systematic reviewEmily R Papadimos, Courtney Claussen, Dianna J Magliano, et al.
Blood Advances|November 20, 2020
Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipientsAdam S Nelson, Daria Heyenbruch, Jeremy D Rubinstein, et al.
Blood Advances|September 8, 2021
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphomaHema Dave, Madeline Terpilowski, Mimi Mai, et al.
Journal of Clinical Pharmacology|August 12, 2017
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic AnalysisNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
Clinical and Experimental Immunology|June 15, 2013
Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapyC R Y Cruz, S Lam, P J Hanley, et al.
Diabetes Care|September 26, 2022
The Portfolio Diet and Incident Type 2 Diabetes: Findings From the Women's Health Initiative Prospective Cohort StudyAndrea J Glenn, Jie Li, Kenneth Lo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 21, 2024
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplantRuby Khoury, Michael S Grimley, Adam S Nelson, et al.
The American Journal of Clinical Nutrition|February 15, 2023
Sugar-sweetened beverage consumption and weight gain in children and adults: a systematic review and meta-analysis of prospective cohort studies and randomized controlled trialsMichelle Nguyen, Sarah E Jarvis, Maria G Tinajero, et al.
Blood|September 29, 2018
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantationLauren P McLaughlin, Rayne Rouce, Stephen Gottschalk, et al.
Molecular Therapy. Methods & Clinical Development|May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy productsJessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Pageof 74